ACTRN12605000323628已完成3 期
A Phase 3, Randomized, Double Blind, Multinational Trial of Intravenous Telavancin Versus Vancomycin for Treatment of Complicated Gram positive Skin and Skin Structure Infections with a Focus on Patients with Infections Due to Methicillin resistant Staphylococcus aureus (ATLAS I)
Theravance, Inc0 个研究点目标入组 750 人开始时间: 2005年9月6日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 750
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 ot stated（—）
- 性别
- All
入选标准
- •Diagnosis of complicated skin and skin structure infections with MRSA either suspected or confirmed as the major cause of the infection:Require at least 7 days of IV antibiotic treatment.
排除标准
- •More than 24 hours of prior therapy or is a treatment failure. Pregnancy.
研究者
相似试验
进行中（未招募）
不适用
Compare Ceftazidime Avibactam + Metronidazole vs Meropenem for hospitalized adults with complicated Intra-Abdominal InfectionsEUCTR2011-003893-97-HRAstraZeneca AB1,106
进行中（未招募）
不适用
Compare Ceftazidime Avibactam + Metronidazole vs Meropenem for hospitalized adults with complicated Intra-Abdominal InfectionsEUCTR2011-003893-97-BGAstraZeneca AB523
进行中（未招募）
不适用
Compare Ceftazidime Avibactam + Metronidazole vs Meropenem for hospitalized adults with complicated Intra-Abdominal InfectionsEUCTR2011-003893-97-PTAstraZeneca AB1,106
进行中（未招募）
不适用
Compare Ceftazidime Avibactam + Metronidazole vs Meropenem for hospitalized adults with complicated Intra-Abdominal InfectionsComplicated Intra-Abdominal Infection (cIAI)MedDRA version: 14.0Level: LLTClassification code 10056570Term: Intra-abdominal infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2011-003895-35-GRAstraZeneca AB1,106
进行中（未招募）
不适用
Compare Ceftazidime Avibactam + Metronidazole vs Meropenem for hospitalized adults with complicated Intra-Abdominal InfectionsComplicated Intra-Abdominal Infection (cIAI)MedDRA version: 14.1Level: LLTClassification code 10056570Term: Intra-abdominal infectionSystem Organ Class: 100000004862EUCTR2011-003893-97-LVAstraZeneca AB1,106